Whitney A. High

4.3k total citations
95 papers, 2.7k citations indexed

About

Whitney A. High is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Whitney A. High has authored 95 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 26 papers in Dermatology and 22 papers in Epidemiology. Recurrent topics in Whitney A. High's work include Cutaneous Melanoma Detection and Management (20 papers), Lanthanide and Transition Metal Complexes (14 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Whitney A. High is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), Lanthanide and Transition Metal Complexes (14 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Whitney A. High collaborates with scholars based in United States, United Kingdom and Portugal. Whitney A. High's co-authors include B.F. Morrey, Mai P. Hoang, Reed Ayers, Shawn E. Cowper, Gary Zito, John P. Chandler, Elizabeth K. Satter, Jonathan Kay, Kyle Molberg and Clay J. Cockerell and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Bone and Joint Surgery.

In The Last Decade

Whitney A. High

92 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Whitney A. High United States 25 625 577 534 512 493 95 2.7k
Rosalynn M. Nazarian United States 28 193 0.3× 471 0.8× 502 0.9× 286 0.6× 457 0.9× 126 2.9k
Arie Orenstein Israel 34 287 0.5× 585 1.0× 405 0.8× 1.1k 2.1× 508 1.0× 117 3.9k
Mary Seabury Stone United States 22 202 0.3× 258 0.4× 226 0.4× 181 0.4× 824 1.7× 99 1.9k
Moritz Wagner Germany 26 110 0.2× 321 0.6× 327 0.6× 638 1.2× 380 0.8× 86 3.4k
Pedro Jaén Spain 23 354 0.6× 157 0.3× 348 0.7× 74 0.1× 622 1.3× 115 2.7k
Camille Françès France 36 75 0.1× 492 0.9× 540 1.0× 214 0.4× 806 1.6× 120 4.0k
Sarah L. Blair United States 30 118 0.2× 811 1.4× 730 1.4× 247 0.5× 107 0.2× 125 2.8k
David Ozog United States 29 82 0.1× 556 1.0× 250 0.5× 394 0.8× 352 0.7× 97 2.6k
Waseem Jerjes United Kingdom 31 84 0.1× 799 1.4× 614 1.1× 264 0.5× 301 0.6× 221 3.6k
Kei Ikeda Japan 34 63 0.1× 597 1.0× 414 0.8× 181 0.4× 459 0.9× 163 4.4k

Countries citing papers authored by Whitney A. High

Since Specialization
Citations

This map shows the geographic impact of Whitney A. High's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney A. High with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney A. High more than expected).

Fields of papers citing papers by Whitney A. High

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whitney A. High. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney A. High. The network helps show where Whitney A. High may publish in the future.

Co-authorship network of co-authors of Whitney A. High

This figure shows the co-authorship network connecting the top 25 collaborators of Whitney A. High. A scholar is included among the top collaborators of Whitney A. High based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whitney A. High. Whitney A. High is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
High, Whitney A., et al.. (2024). Null T‐cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma. Journal of Cutaneous Pathology. 51(8). 614–617.
2.
Li, Hong, Caiguo Zhang, Li Bian, et al.. (2021). Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation. Journal of Investigative Dermatology. 142(2). 390–401. 4 indexed citations
3.
Balaiya, Velmurugan, et al.. (2019). Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling. Molecular Cancer Research. 17(6). 1279–1293. 22 indexed citations
4.
Ellis, Lixia Z., et al.. (2015). A case of multiple atypical nevi with co-localized Basal cell carcinomas on the scalp: insight into the pathogenesis.. PubMed. 14(5). 502–5. 1 indexed citations
5.
High, Whitney A., et al.. (2015). Breast carcinoma masquerading as basal cell carcinoma of the nipple. JAAD Case Reports. 1(6). 361–363. 2 indexed citations
6.
Ellis, Lixia Z., et al.. (2012). Melanoma In Situ Treated Successfully Using Imiquimod After Nonclearance with Surgery: Review of the Literature. Dermatologic Surgery. 38(6). 937–946. 47 indexed citations
7.
Hope, Thomas A., Philip E. LeBoit, Whitney A. High, Yanjun Fu, & Robert C. Brasch. (2012). Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. Magnetic Resonance Imaging. 31(1). 139–144. 6 indexed citations
8.
Lemy, Anne, V. del Mármol, Athanassios Kolivras, et al.. (2010). Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: A single-center experience. Journal of the American Academy of Dermatology. 63(3). 389–399. 13 indexed citations
9.
High, Whitney A., James F. Ranville, Mariah Brown, et al.. (2009). Gadolinium deposition in nephrogenic systemic fibrosis: An examination of tissue using synchrotron x-ray fluorescence spectroscopy. Journal of the American Academy of Dermatology. 62(1). 38–44. 30 indexed citations
10.
Abuav, Rachel, et al.. (2009). Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia. Journal of Cutaneous Pathology. 37(8). 877–880. 8 indexed citations
11.
High, Whitney A., Kim M. Hiatt, James F. Ranville, et al.. (2009). Metal deposition in calcific uremic arteriolopathy. Journal of the American Academy of Dermatology. 61(1). 73–79. 21 indexed citations
12.
Gavino, Alde Carlo P., Glen R. Needham, & Whitney A. High. (2008). Atopic Dermatitis, Patch Testing, and House Dust Mites: A Brief Review. Dermatitis. 19(3). 121–128. 16 indexed citations
13.
Hoang, Mai P., Karen Dresser, Payal Kapur, Whitney A. High, & Meera Mahalingam. (2007). Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Modern Pathology. 21(2). 178–185. 59 indexed citations
14.
High, Whitney A. & Francisco Bravo. (2007). Emerging Diseases in Tropical Dermatology. PubMed. 23. 335–350. 4 indexed citations
15.
High, Whitney A. & Amit G. Pandya. (2006). Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation. Journal of the American Academy of Dermatology. 54(6). 1083–1088. 21 indexed citations
16.
Hoang, Mai P., Whitney A. High, & Kyle Molberg. (2004). Secondary syphilis: a histologic and immunohistochemical evaluation. Journal of Cutaneous Pathology. 31(9). 595–599. 123 indexed citations
17.
High, Whitney A.. (2003). Agave Contact Dermatitis. Dermatitis. 14(4). 213–214. 8 indexed citations
18.
High, Whitney A.. (2003). Agave Contact Dermatitis. Dermatitis. 14(4). 213–213. 1 indexed citations
19.
High, Whitney A. & Melissa Costner. (2003). Persistent scarring, atrophy, and dyspigmentation in a preteen girl with neonatal lupus erythematosus. Journal of the American Academy of Dermatology. 48(4). 626–628. 9 indexed citations
20.
High, Whitney A., et al.. (1999). Extensor triggering in de Quervain's stenosing tenosynovitis. The Journal Of Hand Surgery. 24(6). 1311–1314. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalynn M. Nazarian Breakdown of academic impact, for papers by Arie Orenstein Breakdown of academic impact, for papers by Mary Seabury Stone Breakdown of academic impact, for papers by Moritz Wagner Breakdown of academic impact, for papers by Pedro Jaén Breakdown of academic impact, for papers by Camille Françès Breakdown of academic impact, for papers by Sarah L. Blair Breakdown of academic impact, for papers by David Ozog Breakdown of academic impact, for papers by Waseem Jerjes Breakdown of academic impact, for papers by Kei Ikeda
Rankless by CCL
2026